Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Rosaria De Filippi"'
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-4 (2024)
Abstract Despite the global vaccination campaigns, certain patient groups remain highly vulnerable to SARS-CoV-2 and are at high risk for unfavorable COVID-19 outcomes. As previously shown by our group and a more recent report by Chang Su and coworke
Externí odkaz:
https://doaj.org/article/8a02b22926f4416e90d81424a8c846d0
Autor:
Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonio Pinto, Chrystal M. Paulos, Paolo A. Ascierto
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Nivolumab is an anti-PD1 antibody that has dramatically improved metastatic melanoma patients’ outcomes. Nevertheless, many patients are resistant to PD-1 inhibition, occasionally experiencing severe off-target immune toxicity.
Externí odkaz:
https://doaj.org/article/fc778616ad9c4244b22051d8743c7e29
Autor:
Gianpaolo Marcacci, Nicola Coppola, Emanuela Madonna, Cristina Becchimanzi, Stefania De Pascalis, Silvia D’Ovidio, Stefania Crisci, Piera Maiolino, Rosaria De Filippi, Antonio Pinto
Publikováno v:
Infectious Agents and Cancer, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background To date, there is no information on the safety and efficacy of the novel anti-sarbecoviruses monoclonal antibody sotrovimab administered, as a post-exposure prophylactic measure, during the aplastic phase of autologous stem cell t
Externí odkaz:
https://doaj.org/article/cd5de9fa28e448ed9273f321154ab676
Autor:
Rosaria De Filippi, Fortunato Morabito, Armando Santoro, Giovanni Tripepi, Francesco D’Alò, Luigi Rigacci, Francesca Ricci, Emanuela Morelli, Pier Luigi Zinzani, Antonio Pinto
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background Overweight and obese patients with solid tumors receiving anti-programmed cell death-1 (PD-1)/PD-ligand-1(PD-L1) immune checkpoint inhibitors exhibit improved survival and higher risk of immune-related adverse events (irAEs) than
Externí odkaz:
https://doaj.org/article/f8e8de9a4961465ba54ef26969155fce
Autor:
Gianpaolo Marcacci, Giuseppe Fiorentino, Francesco Volzone, Umberto Falcone, Roberto Parrella, Daniela Donnarumma, Silvia D’Ovidio, Anna Annunziata, Giovanni Micallo, Giuseppe Portella, Annarosaria De Chiara, Rosaria De Filippi, Stefania Crisci, Antonio Pinto
Publikováno v:
Infectious Agents and Cancer, Vol 16, Iss 1, Pp 1-6 (2021)
Abstract Patients with non-hodgkin lymphomas (NHL) represent a population of special interest during the current Coronavirus disease-19 (COVID-19) pandemics. NHLs are associated with disease- and treatment-related immunodeficiencies which may generat
Externí odkaz:
https://doaj.org/article/30f5ce1a2b734cd8a426fabc6ab593e7
Autor:
Stefania Crisci, Raffaele Di Francia, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Rosaria De Filippi, Massimiliano Berretta, Paola Rossi, Antonio Pinto
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
The improved knowledge of pathogenetic mechanisms underlying lymphomagenesis and the discovery of the critical role of tumor microenvironments have enabled the design of new drugs against cell targets and pathways. The Food and Drug Administration (F
Externí odkaz:
https://doaj.org/article/b2737f788f204fcf90cd34a82513151b
Autor:
Stefania Crisci, Concetta Meo, Sara Mele, Giancarla Iaccarino, Antonio Pinto, Rosaria De Filippi, Elvira Pota, Irene Postiglione
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e660-e666
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a2f5193da4a0da7c88b4b260d10811
https://doi.org/10.1016/j.clml.2020.05.020
https://doi.org/10.1016/j.clml.2020.05.020
Autor:
Francesco D'Alo', Antonio Pinto, Giovanni Tripepi, Armando Santoro, Pier Luigi Zinzani, Fortunato Morabito, Francesca Ricci, Emanuela Morelli, Luigi Rigacci, Rosaria De Filippi
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Background Overweight and obese patients with solid tumors receiving anti-programmed cell death-1 (PD-1)/PD-ligand-1(PD-L1) immune checkpoint inhibitors exhibit improved survival and higher risk of immune-related adverse events (irAEs) than those wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dff15eb98d9878b54e2f5b57954972b4
https://doi.org/10.1186/s12967-021-03134-4
https://doi.org/10.1186/s12967-021-03134-4
Autor:
Stefania Crisci, Giuseppe Portella, Umberto Falcone, Rosaria De Filippi, Gianpaolo Marcacci, Antonio Pinto, Roberto Parrella, Giovanni Micallo, Silvia D’Ovidio, Anna Annunziata, Daniela Donnarumma, Annarosaria De Chiara, Francesco Volzone, Giuseppe Fiorentino
Publikováno v:
Infectious Agents and Cancer
Infectious Agents and Cancer, Vol 16, Iss 1, Pp 1-6 (2021)
Infectious Agents and Cancer, Vol 16, Iss 1, Pp 1-6 (2021)
Patients with non-hodgkin lymphomas (NHL) represent a population of special interest during the current Coronavirus disease-19 (COVID-19) pandemics. NHLs are associated with disease- and treatment-related immunodeficiencies which may generate unusual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15aacf45955cd01483de41baab9fd111
https://pubmed.ncbi.nlm.nih.gov/34078415
https://pubmed.ncbi.nlm.nih.gov/34078415
Human gamma delta (γδ) T cells represent heterogeneous subsets of unconventional lymphocytes with an HLA-unrestricted target cell recognition. γδ T cells display adaptive clonally restricted specificities coupled to a powerful cytotoxic function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d77502aba5b294a67f29bbb5b6652575
http://hdl.handle.net/11588/832433
http://hdl.handle.net/11588/832433
